Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ACE2016 |
Trade Name | |
Synonyms | ACE 2016|ACE-2016 |
Drug Descriptions |
ACE2016 are EGFR-targeting T-cells that potentially inhibit growth of EGFR-expressing cancer cells (Cancer Res (2023) 83 (8_Supplement): LB089). |
DrugClasses | EGFR Immune Cell Therapy 4 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ACE2016 | ACE2016 | 0 | 1 |
ACE2016 + Pembrolizumab | ACE2016 Pembrolizumab | 0 | 1 |